Cargando…
Bronchopulmonary dysplasia: clinical aspects and preventive and therapeutic strategies
BACKGROUND: Bronchopulmonary dysplasia (BPD) is the result of a complex process in which several prenatal and/or postnatal factors interfere with lower respiratory tract development, leading to a severe, lifelong disease. In this review, what is presently known regarding BPD pathogenesis, its impact...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5819643/ https://www.ncbi.nlm.nih.gov/pubmed/29463286 http://dx.doi.org/10.1186/s12967-018-1417-7 |
_version_ | 1783301241409896448 |
---|---|
author | Principi, Nicola Di Pietro, Giada Maria Esposito, Susanna |
author_facet | Principi, Nicola Di Pietro, Giada Maria Esposito, Susanna |
author_sort | Principi, Nicola |
collection | PubMed |
description | BACKGROUND: Bronchopulmonary dysplasia (BPD) is the result of a complex process in which several prenatal and/or postnatal factors interfere with lower respiratory tract development, leading to a severe, lifelong disease. In this review, what is presently known regarding BPD pathogenesis, its impact on long-term pulmonary morbidity and mortality and the available preventive and therapeutic strategies are discussed. MAIN BODY: Bronchopulmonary dysplasia is associated with persistent lung impairment later in life, significantly impacting health services because subjects with BPD have, in most cases, frequent respiratory diseases and reductions in quality of life and life expectancy. Prematurity per se is associated with an increased risk of long-term lung problems. However, in children with BPD, impairment of pulmonary structures and function is even greater, although the characterization of long-term outcomes of BPD is difficult because the adults presently available to study have received outdated treatment. Prenatal and postnatal preventive measures are extremely important to reduce the risk of BPD. CONCLUSION: Bronchopulmonary dysplasia is a respiratory condition that presently occurs in preterm neonates and can lead to chronic respiratory problems. Although knowledge about BPD pathogenesis has significantly increased in recent years, not all of the mechanisms that lead to lung damage are completely understood, which explains why therapeutic approaches that are theoretically effective have been only partly satisfactory or useless and, in some cases, potentially negative. However, prevention of prematurity, systematic use of nonaggressive ventilator measures, avoiding supraphysiologic oxygen exposure and administration of surfactant, caffeine and vitamin A can significantly reduce the risk of BPD development. Cell therapy is the most fascinating new measure to address the lung damage due to BPD. It is desirable that ongoing studies yield positive results to definitively solve a major clinical, social and economic problem. |
format | Online Article Text |
id | pubmed-5819643 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-58196432018-02-26 Bronchopulmonary dysplasia: clinical aspects and preventive and therapeutic strategies Principi, Nicola Di Pietro, Giada Maria Esposito, Susanna J Transl Med Review BACKGROUND: Bronchopulmonary dysplasia (BPD) is the result of a complex process in which several prenatal and/or postnatal factors interfere with lower respiratory tract development, leading to a severe, lifelong disease. In this review, what is presently known regarding BPD pathogenesis, its impact on long-term pulmonary morbidity and mortality and the available preventive and therapeutic strategies are discussed. MAIN BODY: Bronchopulmonary dysplasia is associated with persistent lung impairment later in life, significantly impacting health services because subjects with BPD have, in most cases, frequent respiratory diseases and reductions in quality of life and life expectancy. Prematurity per se is associated with an increased risk of long-term lung problems. However, in children with BPD, impairment of pulmonary structures and function is even greater, although the characterization of long-term outcomes of BPD is difficult because the adults presently available to study have received outdated treatment. Prenatal and postnatal preventive measures are extremely important to reduce the risk of BPD. CONCLUSION: Bronchopulmonary dysplasia is a respiratory condition that presently occurs in preterm neonates and can lead to chronic respiratory problems. Although knowledge about BPD pathogenesis has significantly increased in recent years, not all of the mechanisms that lead to lung damage are completely understood, which explains why therapeutic approaches that are theoretically effective have been only partly satisfactory or useless and, in some cases, potentially negative. However, prevention of prematurity, systematic use of nonaggressive ventilator measures, avoiding supraphysiologic oxygen exposure and administration of surfactant, caffeine and vitamin A can significantly reduce the risk of BPD development. Cell therapy is the most fascinating new measure to address the lung damage due to BPD. It is desirable that ongoing studies yield positive results to definitively solve a major clinical, social and economic problem. BioMed Central 2018-02-20 /pmc/articles/PMC5819643/ /pubmed/29463286 http://dx.doi.org/10.1186/s12967-018-1417-7 Text en © The Author(s) 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Review Principi, Nicola Di Pietro, Giada Maria Esposito, Susanna Bronchopulmonary dysplasia: clinical aspects and preventive and therapeutic strategies |
title | Bronchopulmonary dysplasia: clinical aspects and preventive and therapeutic strategies |
title_full | Bronchopulmonary dysplasia: clinical aspects and preventive and therapeutic strategies |
title_fullStr | Bronchopulmonary dysplasia: clinical aspects and preventive and therapeutic strategies |
title_full_unstemmed | Bronchopulmonary dysplasia: clinical aspects and preventive and therapeutic strategies |
title_short | Bronchopulmonary dysplasia: clinical aspects and preventive and therapeutic strategies |
title_sort | bronchopulmonary dysplasia: clinical aspects and preventive and therapeutic strategies |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5819643/ https://www.ncbi.nlm.nih.gov/pubmed/29463286 http://dx.doi.org/10.1186/s12967-018-1417-7 |
work_keys_str_mv | AT principinicola bronchopulmonarydysplasiaclinicalaspectsandpreventiveandtherapeuticstrategies AT dipietrogiadamaria bronchopulmonarydysplasiaclinicalaspectsandpreventiveandtherapeuticstrategies AT espositosusanna bronchopulmonarydysplasiaclinicalaspectsandpreventiveandtherapeuticstrategies |